Dr Thangaraj Devadoss
Associate Professor
SHRI VILE PARLE KELAVANI MANDALS INSTITUTE OF PHARMACY, DHULE
Maharashtra
Expertise:
Pharmacology and Pharmacy
47
Publications
1
Projects
761
Scopus Citations
692
CrossRef
15 Years 3 Months Total Experience
Scopus
761
Citations
16
h-index
CrossRef
692
Citations
16
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
GATE-2003
2003
Department of Education, Ministry of HRD, Government of INdia
Community & Membership
No Data Found
There is currently nothing to display here.
Tamil Nadu Pharmacy Council
Registered PharmacistPersonal Details
Doctor of Philosophy
2011
Central Institute of Post Harvest Engineering and Technology
Master of Arts
2003
N/A
Master of Arts
1998
N/A
Associate Professor
Sep 2022 – Present
SHRI VILE PARLE KELAVANI MANDALS INSTITUTE OF PHARMACY, DHULE
Associate Professor
Oct 2017 – Aug 2022
KVSR SIDDHARTHA COLLEGE OF PHARMACEUTICA
Associate Professor
May 2017 – Oct 2017
Sree vidyanikethan college of pharmacy
Lecturer - Selection Grade
Sep 2015 – Dec 2016
International Medical University
Assistant Professor
Sep 2012 – Sep 2015
KVSR SIDDHARTHA COLLEGE OF PHARMACEUTICA
Associate Professor
Jan 2012 – Sep 2012
Creative Educational Society's College of Pharmacy, Kurnool
Lecturer
Oct 2006 – Aug 2007
JAYA COLLEGE OF PARAMEDICAL SCIENCES, COLLEGE OF PHARMCY (Inst. Code - 224), CHENNAI
Medical and Health Sciences
Scholarly Work
NOVEL QUINOXALINE CARBOXAMIDES: DESIGN, SYNTHESIS AND NEUROPHARMACOLOGICAL EVALUATION AS ANTIDEPRESSANTS, ANXIOLYTICS, AND IN THE MANAGEMENT OF CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
CompletedNo Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
Scholarly Publications
Anti-depressant - like effect of novel 5-HT3 receptor antagonist, (4- 3 benzylpiperazin-1-yl) (3-methoxyquinoxalin-2-yl)methanone (6g) in acute and chronic animal models of depression
Scopus: 2
Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) in experimental mouse models of anxiety
Scopus: 3
Effect of a novel 5-HT3 receptor antagonist carboxamide, 3-methoxy-N-p-tolylquinoxalin-2-carboxamide (QCM-4) on the acute and chronic rodent models of depression
Scopus: 2
Anti-depressant-like activity of a novel serotonin type-3 (5-HT 3) receptor antagonist in rodent models of depression
Scopus: 10
IDO and TGF-β Inhibitors for the Treatment of Lung Cancer
Drugs Under Clinical Trials for the Treatment of Migraine
10.1007/978-981-97-4529-6_12
Scopus: 1
Discovery of new anti-depressants from structurally novel 5-HT3 receptor antagonists: Design, synthesis and pharmacological evaluation of 3-ethoxyquinoxalin-2-carboxamides
Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist
Scopus: 10
Showing 1 to 8 of 47 publications